Submitted by Anonymous (not verified) on 12 June 2025 - 15:37
Opinion/decision on a Paediatric investigation plan (PIP): Lynparza, Olaparib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0148/2024
Source: